Protocol for using Multiomics2Targets to identify targets and driver kinases for cancer cohorts profiled with multi-omics assays

The availability of multi-omics data applied to profile cancer cohorts is rapidly increasing. Here, we present a protocol for Multiomics2Targets, a computational pipeline that can identify driver cell signaling pathways, protein kinases, and cell-surface targets for immunotherapy. We describe steps...

Full description

Saved in:
Bibliographic Details
Published in:STAR protocols Vol. 5; no. 4; p. 103457
Main Authors: Marino, Giacomo B., Deng, Eden Z., Clarke, Daniel J.B., Diamant, Ido, Resnick, Adam C., Ma, Weiping, Wang, Pei, Ma’ayan, Avi
Format: Journal Article
Language:English
Published: Elsevier Inc 01-12-2024
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The availability of multi-omics data applied to profile cancer cohorts is rapidly increasing. Here, we present a protocol for Multiomics2Targets, a computational pipeline that can identify driver cell signaling pathways, protein kinases, and cell-surface targets for immunotherapy. We describe steps for preparing the data, uploading files, and tuning parameters. We then detail procedures for running the workflow, visualizing the results, and exporting and sharing reports containing the analysis. For complete details on the use and execution of this protocol, please refer to Deng et al.1 [Display omitted] •A comprehensive workflow to analyze data from cancer patient cohorts•Workflow to analyze transcriptomics, proteomics, and phosphoproteomics•Results are produced in a research-paper-like report that can be shared Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics. The availability of multi-omics data applied to profile cancer cohorts is rapidly increasing. Here, we present a protocol for Multiomics2Targets, a computational pipeline that can identify driver cell signaling pathways, protein kinases, and cell-surface targets for immunotherapy. We describe steps for preparing the data, uploading files, and tuning parameters. We then detail procedures for running the workflow, visualizing the results, and exporting and sharing reports containing the analysis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2666-1667
2666-1667
DOI:10.1016/j.xpro.2024.103457